| Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With Anlotinib (NCT05453383) | Shen Feng | 2022-07-08 |
| Study of Microwave Spherical Ablation and Traditional Microwave Ablation in Single Hepatocellular Carcinoma ≤5cm (NCT05361538) | Tianjin Third Central Hospital | 2022-06-22 |
| A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors (NCT05293496) | MacroGenics | 2022-04-19 |
| A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors (NCT05070247) | Takeda | 2022-04-14 |
| Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer (NCT05540925) | Eastern Hepatobiliary Surgery Hospital | 2022-01-01 |
| GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies (NCT05003895) | National Cancer Institute (NCI) | 2021-12-08 |
| Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma (NCT05100082) | Takeda | 2021-11-17 |
| Study of PF-07263689 in Participants With Selected Advanced Solid Tumors (NCT05061537) | Pfizer | 2021-10-20 |
| Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC (NCT04912765) | National Cancer Centre, Singapore | 2021-04-15 |
| Volatile Organic Compounds for the Assessment of Liver Disease (NCT04620538) | Imperial College London | 2021-04-01 |
| Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma (NCT03937830) | National Cancer Institute (NCI) | 2021-03-10 |
| Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers (NCT04682847) | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 2020-11-19 |
| PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) (NCT04484636) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| The PLATON Network (NCT05489250) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-28 |
| Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers (NCT04692454) | Taipei Medical University WanFang Hospital | 2020-08-31 |
| High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors (NCT04033107) | Zhongnan Hospital | 2020-07-01 |
| Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC (NCT04212273) | Tianjin Third Central Hospital | 2019-12-21 |
| Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC (NCT04212286) | Tianjin Third Central Hospital | 2019-10-23 |
| A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion (NCT03971201) | White Plains Hospital | 2019-09-06 |
| Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers (NCT03785210) | National Cancer Institute (NCI) | 2019-06-05 |
| Sharing Decision-making Program for HCC Patients Treatment Decisions (NCT03926039) | National Taipei University of Nursing and Health Sciences | 2019-05-01 |
| Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma (NCT03748927) | National Cancer Institute (NCI) | 2019-04-08 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| Measuring and Improving the Safety of Test Result Follow-Up (NCT04166240) | VA Office of Research and Development | 2018-10-01 |
| Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma (NCT03572582) | AIO-Studien-gGmbH | 2018-06-14 |
| Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer (NCT03480152) | National Cancer Institute (NCI) | 2018-05-18 |
| DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC) (NCT03474354) | Malagari Katerina | 2018-05-02 |
| Characterization of Methylation Patterns in Hepatocellular Carcinoma (NCT04264754) | Nucleix Ltd. | 2018-02-13 |
| Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer (NCT02929082) | Assistance Publique - Hôpitaux de Paris | 2018-01-23 |
| Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea (NCT03586050) | Ethicon, Inc. | 2017-12-11 |
| Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers (NCT03195699) | Tvardi Therapeutics, Incorporated | 2017-11-15 |
| Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma (NCT03253536) | Ludwig-Maximilians - University of Munich | 2017-07-10 |
| AFPᶜ³³²T in Advanced HCC (NCT03132792) | Adaptimmune | 2017-05-08 |
| Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. (NCT02947165) | Novartis Pharmaceuticals | 2017-04-25 |
| Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) (NCT02958163) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2017-02-20 |
| Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer (NCT03037437) | The University of Texas Health Science Center at San Antonio | 2017-02-16 |
| Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver (NCT03151213) | Sherief Abd-Elsalam | 2017-01-01 |
| A Longitudinal Observational Study of the Natural History and Management of Patients With HCC (NCT02954094) | Target PharmaSolutions, Inc. | 2016-12-01 |
| Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery (NCT03594929) | Singapore General Hospital | 2016-08-15 |
| Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers (NCT02838836) | University of Missouri-Columbia | 2016-07-01 |
| Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow (NCT03551951) | University of Missouri-Columbia | 2016-07-01 |
| HCC Patient Preferences in Japan (NCT02616692) | Bayer | 2016-05-09 |
| LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors (NCT02649868) | National Institutes of Health Clinical Center (CC) | 2016-01-12 |
| Prospective Tumor Response Evaluation (NCT02787954) | The University of Texas Health Science Center, Houston | 2016-01-01 |
| Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer (NCT02292173) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-18 |
| A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin (NCT02141906) | University of Texas Southwestern Medical Center | 2015-01-21 |
| Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer (NCT02288507) | University of Hawaii | 2014-11-01 |
| A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer (NCT02082210) | Eli Lilly and Company | 2014-03-07 |
| Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm (NCT02528526) | University of Zurich | 2014-02-01 |
| Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer (NCT02069145) | OncoMed Pharmaceuticals, Inc. | 2014-01-01 |
| Assessment of Frailty in Patients With Advanced Hepatocellular Cancers (NCT02482259) | Newcastle-upon-Tyne Hospitals NHS Trust | 2013-12-01 |
| T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer (NCT01967823) | National Cancer Institute (NCI) | 2013-10-24 |
| HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC) (NCT01849588) | Massachusetts General Hospital | 2013-05-01 |
| Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer (NCT01807156) | Emory University | 2013-03-01 |
| Sorafenib + mFOLFOX for Hepatocellular Carcinoma (NCT01775501) | Massachusetts General Hospital | 2013-01-01 |
| Autologous Natural Killer T Cells Infusion for the Treatment of Cancer (NCT01801852) | Chinese PLA General Hospital | 2013-01-01 |
| Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery (NCT01655641) | Tribhuvan University Teaching Hospital, Institute Of Medicine. | 2012-07-01 |
| Major RF Ablations of Hepatomas Under MR Thermometry Monitoring (NCT01486134) | Assistance Publique - Hôpitaux de Paris | 2012-06-20 |
| TRC105 for Liver Cancer That Has Not Responded to Sorafenib (NCT01375569) | National Cancer Institute (NCI) | 2011-06-22 |
| Adult-to-Adult Living Donor Transplant Cohort Study (NCT01619475) | Arbor Research Collaborative for Health | 2011-02-01 |
| A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation (NCT02073435) | Northwestern University | 2010-10-01 |
| Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (NCT01078311) | South West Sydney Local Health District | 2010-02-01 |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors (NCT01012362) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer (NCT01522937) | University of Michigan Rogel Cancer Center | 2009-10-01 |
| Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients (NCT01507740) | Medical University Innsbruck | 2009-07-01 |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma (NCT00669136) | Lisa H. Butterfield, Ph.D. | 2009-06-01 |
| Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer (NCT00813293) | Beth Israel Deaconess Medical Center | 2009-06-01 |
| Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients (NCT00997022) | Columbia University | 2009-05-01 |
| Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer (NCT00909558) | Envita Medical Center, Inc. | 2009-05-01 |
| A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer (NCT03026803) | City of Hope Medical Center | 2006-11-01 |
| Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases (NCT00465023) | Massachusetts General Hospital | 2003-06-01 |
| Clinical Application of Image-Guided Liver Surgery (NCT00878215) | Washington University School of Medicine | 2002-10-24 |